{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T16:35:04Z","timestamp":1649003704066},"reference-count":21,"publisher":"Europa Digital & Publishing","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.4244\/eijv12i10a208","type":"journal-article","created":{"date-parts":[[2016,11,20]],"date-time":"2016-11-20T11:18:03Z","timestamp":1479640683000},"page":"1271-1278","source":"Crossref","is-referenced-by-count":2,"title":["Biodegradable polymer-based, argatroban-eluting, cobalt-chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned"],"prefix":"10.4244","volume":"12","author":[{"given":"Yoshihiro","family":"Morino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tobaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hirohata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kozuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-20161120104744-0","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.111.046599","article-title":"Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry.","volume":"125","author":"Kimura T.","year":"2012","journal-title":"Circulation."},{"key":"key-20161120104744-1","doi-asserted-by":"publisher","first-page":"14E","DOI":"10.1016\/S0002-9149(98)00191-X","article-title":"Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and\/or remodeling.","volume":"81","author":"Schwartz RS.","year":"1998","journal-title":"Am J Cardiol."},{"key":"key-20161120104744-2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00019501-200409000-00002","article-title":"Prevention of restenosis after stenting: the emerging role of inflammation.","volume":"15","author":"Versaci F.","year":"2004","journal-title":"Coron Artery Dis."},{"key":"key-20161120104744-3","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1046\/j.1538-7836.2003.00100.x","article-title":"Prolonged procoagulant activity on overstretch-injured coronary arteries in pigs.","volume":"1","author":"Abendschein DR.","year":"2003","journal-title":"J Thromb Haemost."},{"key":"key-20161120104744-4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/j.1440-1681.1997.tb02694.x","article-title":"Effects of locally administered argatroban on restenosis after balloon angioplasty: experimental and clinical study.","volume":"24","author":"Imanishi T.","year":"1997","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"key-20161120104744-5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1253\/circj.68.615","article-title":"Local delivery of argatroban for the prevention of restenosis after coronary balloon angioplasty: a prospective randomized pilot study.","volume":"68","author":"Itoh T.","year":"2004","journal-title":"Circ J."},{"key":"key-20161120104744-6","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1253\/circj.CJ-09-0113","article-title":"Factors that influence measurements and accurate evaluation of stent apposition by optical coherence tomography. Assessment using a phantom model.","volume":"73","author":"Sawada T.","year":"2009","journal-title":"Circ J."},{"key":"key-20161120104744-7","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1253\/circj.CJ-14-0337","article-title":"Vascular response to drug-eluting stent with biodegradable vs. durable polymer. Optical coherence tomography substudy of the NEXT.","volume":"78","author":"Kubo T.","year":"2014","journal-title":"Circ J."},{"key":"key-20161120104744-8","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE.","year":"2007","journal-title":"Circulation."},{"key":"key-20161120104744-9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1055\/s-0038-1642736","article-title":"Assessment of factors important in atherosclerotic occlusion and restenosis.","volume":"74","author":"Schwartz SM.","year":"1995","journal-title":"Thromb Haemost."},{"key":"key-20161120104744-10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-0038-1656050","article-title":"Inhibition of leucocyte and platelet adhesion reduces neointimal hyperplasia after arterial injury.","volume":"77","author":"Golino P.","year":"1997","journal-title":"Thromb Haemost."},{"key":"key-20161120104744-11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0140-6736(97)11128-X","article-title":"Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II).","volume":"352","author":"Serruys PW.","year":"1998","journal-title":"Lancet."},{"key":"key-20161120104744-12","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1053\/euhj.2001.2608","article-title":"Comparison of the heparin coated vs the uncoated Jostent--no influence on restenosis or clinical outcome.","volume":"22","author":"Wohrle J.","year":"2001","journal-title":"Eur Heart J."},{"key":"key-20161120104744-13","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.","volume":"346","author":"Morice MC.","year":"2002","journal-title":"N Engl J Med."},{"key":"key-20161120104744-14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1161\/01.CIR.0000047700.58683.A1","article-title":"TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions.","volume":"107","author":"Grube E.","year":"2003","journal-title":"Circulation."},{"key":"key-20161120104744-15","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","article-title":"Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.","volume":"115","author":"Camenzind E.","year":"2007","journal-title":"Circulation."},{"key":"key-20161120104744-16","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.4244\/EIJV8I9A156","article-title":"First-in-man evaluation of the MOMO cobalt-chromium carbon-coated stent.","volume":"8","author":"Kesavan S.","year":"2013","journal-title":"EuroIntervention."},{"key":"key-20161120104744-17","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jacc.2004.01.023","article-title":"First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial.","volume":"43","author":"Abizaid A.","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"key-20161120104744-18","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/eurheartj\/ehp127","article-title":"MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses.","volume":"30","author":"Onuma Y.","year":"2009","journal-title":"Eur Heart J."},{"key":"key-20161120104744-19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4244\/EIJV4I1A22","article-title":"The neointimal response to stents eluting tacrolimus from a degradable coating depends on the balance between polymer degradation and drug release.","volume":"4","author":"van Beusekom H.","year":"2008","journal-title":"EuroIntervention."},{"key":"key-20161120104744-20","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jacc.2011.12.016","article-title":"Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent.","volume":"59","author":"Meredith IT.","year":"2012","journal-title":"J Am Coll Cardiol."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T11:47:37Z","timestamp":1601207257000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/107th_issue\/208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["EIJV12I10A208"],"URL":"https:\/\/doi.org\/10.4244\/eijv12i10a208","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}